scholarly article | Q13442814 |
P50 | author | Elliott D. Kieff | Q43399614 |
P2093 | author name string | M Heller | |
T Dambaugh | |||
P2860 | cites work | Complexity of EBV homologous DNA in continous lymphoblastoid cell lines | Q40023900 |
Heterogeneity of Epstein-Barr virus II. Induction of early antigens (EA) by complementation | Q40087369 | ||
Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus | Q40091405 | ||
A new tumour-derived transforming strain of Epstein–Barr virus | Q40141830 | ||
Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs | Q40172247 | ||
Epstein-Barr virus RNA in Burkitt tumor tissue | Q40237093 | ||
The structure of the termini of the DNA of Epstein-Barr virus | Q40251515 | ||
Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line | Q40706383 | ||
Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells | Q43805008 | ||
DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative | Q45803144 | ||
NC37-R1 Epstein-Barr Virus (EBV): a Possible Recombinant between Intracellular NC 37 Viral DNA and Superinfecting P3HR-1 EBV | Q45803889 | ||
Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line | Q45893613 | ||
CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA) | Q46478873 | ||
Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ | Q27860770 | ||
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
A membrane-filter technique for the detection of complementary DNA | Q29618219 | ||
Organization of repeated regions within the Epstein-Barr virus DNA molecule | Q33913142 | ||
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs | Q34251907 | ||
DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA | Q34255167 | ||
Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro | Q35058722 | ||
Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells | Q35076361 | ||
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes | Q35093948 | ||
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference | Q35129086 | ||
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA | Q35235890 | ||
Linkage map of the fragments of herpesvirus papio DNA | Q35235906 | ||
Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. | Q35236052 | ||
Cleavage of Epstein-Barr virus DNA by restriction endonucleases EcoRI, HindIII and BamI | Q36169724 | ||
Epstein-Barr Virus-Specific RNA III. Mapping of DNA Encoding Viral RNA in Restringent Infection | Q36491336 | ||
DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration | Q36500605 | ||
Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line | Q36507642 | ||
DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus | Q36523145 | ||
DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus | Q36526302 | ||
DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness | Q36532154 | ||
Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells | Q36542435 | ||
Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases | Q36595151 | ||
Sites of sequence variability in Epstein-Barr virus DNA from different sources | Q37333345 | ||
Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus | Q37500327 | ||
Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid | Q37501600 | ||
DNA of Epstein-Barr Virus. II. Comparison of the Molecular Weights of Restriction Endonuclease Fragments of the DNA of Epstein-Barr Virus Strains and Identification of End Fragments of the B95-8 Strain | Q37506712 | ||
Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells | Q37584760 | ||
Epstein-Barr virus: Structure of the viral DNA and analysis of viral RNA in infected cells | Q38032820 | ||
Biological differences between epstein-barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction | Q39932314 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 632-648 | |
P577 | publication date | 1981-05-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells | |
P478 | volume | 38 |
Q36886069 | A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes |
Q35788728 | A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease |
Q37577729 | A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection |
Q36697700 | A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant |
Q36872412 | Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma |
Q37398140 | An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines |
Q36911884 | An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200) |
Q33854424 | An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A |
Q36628631 | An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro |
Q41690592 | An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA |
Q36821061 | BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication |
Q36896856 | Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity |
Q37111825 | Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia |
Q36596456 | DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group |
Q36799631 | Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia |
Q37393138 | Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family |
Q40142296 | Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region |
Q37604184 | Detection of autonomous replicating sequences (ars) in the genome of Epstein-Barr virus |
Q45840383 | Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection |
Q44521049 | Differential expression of the major histocompatibility antigen complex (MHC) on a series of Burkitt's lymphoma lines |
Q35140295 | Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus |
Q36481549 | Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques |
Q36700868 | Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants |
Q36924224 | Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion |
Q36934572 | Epstein-Barr virus DNA. X. Direct repeat within the internal direct repeat of Epstein-Barr virus DNA |
Q35237835 | Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells |
Q36922358 | Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells |
Q37856451 | Epstein-Barr virus genetics: talking about the BAC generation |
Q36464527 | Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential |
Q36637806 | Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. |
Q36810617 | Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. |
Q36686055 | Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. |
Q33796173 | Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus |
Q36655212 | Epstein-Barr virus recombinants from overlapping cosmid fragments |
Q36782491 | Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes |
Q36914351 | Epstein-Barr virus with heterogeneous DNA disrupts latency |
Q37569575 | Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer |
Q36888549 | Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells |
Q36865083 | Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells |
Q90148663 | First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus |
Q36873148 | Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. |
Q35884417 | Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene |
Q36922745 | Herpesvirus saimiri strain variability |
Q36927503 | Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA |
Q36244523 | Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome |
Q37611003 | Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells |
Q36122562 | Identification of an Epstein-Barr virus-specific desoxyribonuclease gene using complementary DNA |
Q36669953 | Immune regulation in Epstein-Barr virus-associated diseases |
Q36904956 | Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region |
Q70182227 | Localization polymorphism of EBV DNA genomes in the chromosomes of Burkitt lymphoma cell lines |
Q36925615 | Long internal direct repeat in Epstein-Barr virus DNA |
Q36855762 | Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection. |
Q37164004 | Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses |
Q36927515 | Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye |
Q35616566 | Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site |
Q36922228 | Organization of the Epstein-Barr virus DNA molecule. II. Fine mapping of the boundaries of the internal repeat cluster of B95-8 and identification of additional small tandem repeats adjacent to the HR-1 deletion |
Q36908739 | Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcr |
Q36900189 | P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread |
Q36862582 | Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA. |
Q36974652 | Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo |
Q36905838 | RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells |
Q37409177 | Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro |
Q35832104 | Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. |
Q36314098 | Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes |
Q37606965 | Rescue of transforming Epstein-Barr virus (EBV) from EBV-genome-positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA |
Q36932967 | Sequence complexity of circular Epstein-Bar virus DNA in transformed cells |
Q36925687 | Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections |
Q40133709 | Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells |
Q40100177 | Synchronous and sequential activation of latently infected Epstein-Barr virus genomes |
Q41568680 | The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. |
Q36637817 | The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. |
Q36685081 | The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential |
Q41455592 | Transfer of the Epstein-Barr virus genes coding for small RNAs to human lymphoid cells with a vector carrying a dominant selectable marker |
Q36903105 | Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H |
Q36598726 | Two distant regions of the Epstein-Barr virus genome with sequence homologies have the same orientation and involve small tandem repeats |
Q36889039 | Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells |
Q37579511 | U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 |
Q36697392 | Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro |
Search more.